Cefpodoxime proxetil and Sertraline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefpodoxime proxetil and Sertraline. Common interactions include mental disorder among females and aortic stenosis among males.

The phase IV clinical study analyzes what interactions people who take Cefpodoxime proxetil and Sertraline have. It is created by eHealthMe based on reports of 27 people who take Cefpodoxime proxetil and Sertraline from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

27 people who take Cefpodoxime proxetil and Sertraline together, and have interactions are studied.

What is Cefpodoxime proxetil?

Cefpodoxime proxetil has active ingredients of cefpodoxime proxetil. eHealthMe is studying from 1,212 Cefpodoxime proxetil users for its effectiveness, alternative drugs and more.

What is Sertraline?

Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 129,417 Sertraline users for its effectiveness, alternative drugs and more.

Number of Cefpodoxime proxetil and Sertraline reports submitted per year:

Common Cefpodoxime Proxetil and Sertraline drug interactions by gender *:

female:

Mental disorder
Mental status changes
Multiple injuries
Muscular weakness
Nasopharyngitis
Natural killer cell count decreased
Nausea
Arthralgia
Asthenia
Leukocytosis

male:

Aortic stenosis
Bradycardia
Fatigue
Hypoaesthesia
Pain
Pneumonia
Purulent discharge
Rectal cancer
Skin hypertrophy
Skin wound

Common Cefpodoxime Proxetil and Sertraline drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaemia
Arthralgia
Asthenia
General physical health deterioration
Hepatic enzyme increased
Hepatosplenomegaly
Hypertriglyceridaemia
Hypothyroidism
Influenza
Leukocytosis

40-49:

n/a

50-59:

Aortic stenosis
Bradycardia
Cardiac disorder

60+:

Decreased appetite
Pulmonary embolism
Pain
Pneumonia
Purulent discharge
Rectal cancer
Seasonal allergy
Skin hypertrophy
Skin wound
Soft tissue infection

Common conditions people have *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 29.63%
Multiple Myeloma (cancer of the plasma cells): 5 people, 18.52%
Immunodeficiency Common Variable: 5 people, 18.52%
Pain: 3 people, 11.11%
Infection: 3 people, 11.11%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 7.41%
Prostate Cancer: 2 people, 7.41%
Post-Traumatic Stress Disorder: 2 people, 7.41%
Mood Swings (an extreme or rapid change in mood): 2 people, 7.41%
Inflammation: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Cefpodoxime proxetil and Sertraline?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Cefpodoxime proxetil (1,212 reports)
Sertraline (129,417 reports)